Under construction – not a live service
Sign in
Taking people in ChinaNo phase

Following lung health in people with early COPD over time

Tracks lung function decline in adults with early COPD, including smoking and scans.

Plain-language title generated from the registry record
Registry title: Lung Health of Early COPD: A Multi-center Cohort Study

Key facts

Where
Beijing and Zunyi, ChinaSee the 2 sites

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 35 and 75 years old?

Source: NCT05466396, who can take part

Where in China

  • China-Japan Friendship HospitalBeijing, ChinaTaking people
  • Affiliated Hospital of Zunyi Medical UniversityZunyi, ChinaTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Ting YANG
Trial code
NCT05466396
Record updated
17 February 2025
Original description
This is a multi-center, prospective, cohort study in early COPD patients. This study aims to elucidate the lung function decline and its association with smoking and other risk factors. Other biomarkers and image markers from chest CT scan are also analyzed to investigate the lung function in early COPD patients.Read full original descriptionShow less

Lung Health of Early Chronic Obstructive Pulmonary Disease: A Multi-center Cohort Study

This is a multi-center, prospective, cohort study in early COPD patients. This study aims to elucidate the lung function decline and its association with smoking and other risk factors. Other biomarkers and image markers from chest CT scan are also analyzed to investigate the lung function in early COPD patients.

Inclusion: Gender: male or female; Age: 35-75 years old; post-bronchodilator spirometry: FEV1/FVC < 0.8 and FEV1%pred ≥80%.

Exclusion: Other diseases may affect lung function, like lung cancer, bronchiectasis, interstitial lung disease or chest surgery; Dementia or other severe neurological disease; Conditions that contraindicated lung function test; BMI > 35 kg/m2; Pregnancy.

ClinicalTrials.gov NCT05466396